Quantcast

Latest Clinical research Stories

2014-08-05 12:31:12

TUCSON, Ariz., Aug. 5, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces a new agreement with Quintiles, Inc. to offer College of American Pathology (CAP)-standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. This is great news for patients as China is one of the only countries in the world that requires all patient samples be tested in China,...

2014-08-05 08:33:41

Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide. ANN ARBOR, Mich. and DENVER, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Paradigm has announced today they have initiated genomic testing for Pharmatech's AccessPPM Cancer Registry. Pharmatech's AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials....

2014-08-05 08:33:24

QUÉBEC CITY, Aug. 5, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics(®) US, LLC, ("ASCEND"). Under the terms of the agreement, expected to start in the fourth quarter of 2014, Aeterna Zentaris will use its newly established commercial structure to market, in specific U.S. territories, ASCEND's EstroGel(® )a non-patch transdermal U.S. Food & Drug...

2014-08-04 12:30:57

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/restless_legs_syndrome_global_clinical_trials_review.html Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, "Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the...

2014-08-04 08:28:51

HAYWARD, Calif., Aug. 4, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a re-inspection of the Company's Hayward, California manufacturing facility from June 16 to July 31, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with seven inspectional observations, two of which are designated as repeat observations. The FDA did not provide any status or classification to these...

2014-08-01 23:06:14

Cambridge Biomedical Inc announces contract with a major biopharmaceutical company for a GCLP Bioanalytical Assays and Sample Testing project extending into 2015. Boston, MA (PRWEB) August 01, 2014 Cambridge Biomedical Inc announces contract with a major biopharmaceutical company for a GCLP Bioanalytical Assays and Sample Testing project extending into 2015. Cambridge Biomedical’s experience in bioanalytical assay development, optimization, validation and diagnostic testing coupled...

2014-08-01 16:24:12

SOUTH PLAINFIELD, N.J., Aug. 1, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on July 31, 2014 it approved non-statutory stock options to purchase an aggregate of 67,700 shares of its common stock to seven new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our new hires' employment compensation. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The inducement grants were approved by PTC's...

2014-08-01 12:27:02

Persistent gender inequity at FDA has led to 26 approved drugs for men, ZERO for women WASHINGTON, Aug. 1, 2014 /PRNewswire-USNewswire/ -- In the latest call for gender equity in the approval of treatments for sexual dysfunction, more than 60 doctors and leading medical experts from across the country have penned an open letter questioning the Food and Drug Administration's (FDA) decision to approve 26 drugs marketed for the most common form of male sexual dysfunction compared with...

2014-08-01 12:26:51

Persistent gender inequity at FDA has led to 26 approved drugs for men, ZERO for women WASHINGTON, Aug. 1, 2014 /PRNewswire-USNewswire/ -- In the latest call for gender equity in the approval of treatments for sexual dysfunction, more than 60 doctors and leading medical experts from across the country have penned an open letter questioning the Food and Drug Administration's (FDA) decision to approve 26 drugs marketed for the most common form of male sexual dysfunction compared with...

2014-08-01 08:26:14

PLYMOUTH MEETING, Pa., Aug. 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial results on Monday, August 11, 2014 at 9:00 AM ET. CEO Dr. J. Joseph Kim and CFO Peter Kies will discuss second quarter earnings, provide a corporate update, and participate in a live Q&A with analysts. The update will include clinical development plans for VGX-3100, Inovio's immune therapy...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'